New Zealand - engelsk - Medsafe (Medicines Safety Authority)

phebra nz limited - metaraminol tartrate 18.96 mg/ml equivalent to metaraminol 10 mg - solution for injection - 10 mg/ml - active: metaraminol tartrate 18.96 mg/ml equivalent to metaraminol 10 mg excipient: sodium chloride sodium hydroxide sodium metabisulfite tartaric acid water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - metaraminol tartrate 0.95 mg/ml equivalent to metaraminol 0.5mg/ml;   - solution for injection - 0.5 mg/ml - active: metaraminol tartrate 0.95 mg/ml equivalent to metaraminol 0.5mg/ml   excipient: sodium chloride sodium metabisulfite water for injection - latest regulatory activity

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

max health limited - metaraminol tartrate 19 mg/ml equivalent to metaraminol 10mg/ml;   - solution for injection - 10 mg/ml - active: metaraminol tartrate 19 mg/ml equivalent to metaraminol 10mg/ml   excipient: nitrogen sodium chloride sodium metabisulfite water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or scepticaemia.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

juno pharmaceuticals nz limited - metaraminol tartrate 0.949 mg/ml equivalent to metaraminol 0.50mg/ml - solution for injection - 2.5 mg/5ml - active: metaraminol tartrate 0.949 mg/ml equivalent to metaraminol 0.50mg/ml excipient: hydrochloric acid sodium chloride water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

juno pharmaceuticals nz limited - metaraminol tartrate 0.949 mg/ml equivalent to metaraminol 0.50mg/ml - solution for injection - 5 mg/10ml - active: metaraminol tartrate 0.949 mg/ml equivalent to metaraminol 0.50mg/ml excipient: hydrochloric acid sodium chloride water for injection - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metaraminol tartrate - solution for injection - 10mg/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metaraminol tartrate - solution for injection - 500microgram/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metaraminol tartrate - solution for injection - 500microgram/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metaraminol tartrate - solution for injection - 500microgram/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metaraminol tartrate - solution for injection - 500microgram/1ml